PHARMACEUTICAL INDUSTRY: Optimistic to Reach Rp.50 Trillion Turnover 2012: http://www.gpfarmasi.org/index.php?option=com_content&view=article&id=609:industri-farmasi-optimistis-omzet-2012-tembus-rp50-triliun&catid=41:seputar-farmasi/9 August 2012
The pharmaceutical industry is optimistic about achieving a turnover in 2012 able to break the Rp50 trillion at the end of the semester despite the predicted growth slightly contracted. Executive Director of the Pharmaceutical Industry Association of Indonesia (GPFI) said the industry is sure to grow 15% in 2012 compared with the year-ago period. Behavioral change is predicted to greatly affect the purchasing power for these medicinal products. Changes in people's behavior are predicted to greatly affect the purchasing power of these medicinal products.
Opportunities in the Pharmaceutical Sector : http://binfar.kemkes.go.id/2014/05/peluang-di-sektor-farmasi/12 May 2014
Starting operation of Social Security Agency (BPJS) per January 1, 2014 to add a business opportunity for the pharmaceutical industry in the country. Government efforts to improve public health, national health insurance will drive the demand for drugs-especially generic drugs.
Increased awareness of the importance of the productive age population health can also foster public expenditure on pharmaceutical products nationwide. In the road map to the National Health Insurance 2012-2019, targeted as much as 121.6 million people insured by health BPJS this year.
To 2019 the entire population, or about 257.5 million people already guaranteed everything. It is mandated by Law No. 40 Year 2004 on National Social Security System and the Law 24 of 2011 on the Social Security Agency.
Medicinal and Pharmaceutical Products Manufacturing in Indonesia
Indonesia Industry Report and Market Research
April 16, 2018
Industry Code : C35221
Forecast to : 2022
Definition
Medicinal and Pharmaceutical Products Manufacturing in Indonesia Manufacturing drugs, medicinal chemicals or other pharmaceutical products, except herbal medicine, for human or veterinary use.
Activities
The primary activities of firms in this industry are:
The Medicinal and Pharmaceutical Products Manufacturing industry in Indonesia research report contain trend analysis, statistics, market size information, industry growth rates as well as major competitors.
Major market segments are identified and also those forces affecting demand and supply within this industry. Performance analysis includes emerging industry trends as well as recent results and performance of each key company. Drawing on the depth of information DIS also provides 5 year forecasts for this industry.
The comprehensive study also examines details such as the barriers to entry, operating cost structure, technology & systems and domestic & international markets. Tables and statistics include: Industry revenue, exports, imports, wages and number of companies in the industry, Industry growth and geographic regional data.